Literature DB >> 33043595

Co-staining of KCa 3.1 Channels in NSCLC Cells with a Small-Molecule Fluorescent Probe and Antibody-Based Indirect Immunofluorescence.

Kathrin Brömmel1,2, Sarah Maskri1, Etmar Bulk3, Zoltan Pethő3, Marius Rieke3, Thomas Budde4,2, Oliver Koch1, Albrecht Schwab3,2, Bernhard Wünsch1,2.   

Abstract

The Ca2+ activated potassium channel 3.1 (KCa 3.1) is involved in critical steps of the metastatic cascade, such as proliferation, migration, invasion and extravasation. Therefore, a fast and efficient protocol for imaging of KCa 3.1 channels was envisaged. The novel fluorescently labeled small molecule imaging probes 1 and 2 were synthesized by connecting a dimethylpyrrole-based BODIPY dye with a derivative of the KCa 3.1 channel inhibitor senicapoc via linkers of different length. Patch-clamp experiments revealed the inhibition of KCa 3.1 channels by the probes confirming interaction with the channel. Both probes 1 and 2 were able to stain KCa 3.1 channels in non-small-cell lung cancer (NSCLC) cells following a simple, fast and efficient protocol. Pre-incubation with unlabeled senicapoc removed the punctate staining pattern showing the specificity of the new probes 1 and 2. Staining of the channel with the fluorescently labeled senicapoc derivatives 1 or 2 or with antibody-based indirect immunofluorescence yielded identical or very similar densities of stained KCa 3.1 channels. However, co-staining using both methods did not lead to the expected overlapping punctate staining pattern. This observation was explained by docking studies showing that the antibody used for indirect immunofluorescence and the probes 1 and 2 label different channel populations. Whereas the antibody binds at the closed channel conformation, the probes 1 and 2 bind within the open channel.
© 2020 The Authors. ChemMedChem published by Wiley-VCH GmbH.

Entities:  

Keywords:  KCa3.1 channel; co-staining; fluorescent probes; non-small cell lung cancer cells; senicapoc derivatives

Year:  2020        PMID: 33043595      PMCID: PMC7756743          DOI: 10.1002/cmdc.202000652

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  18 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  Subcellular distribution of calcium-sensitive potassium channels (IK1) in migrating cells.

Authors:  Albrecht Schwab; Andrea Wulf; Christoph Schulz; Wolfram Kessler; Volodymyr Nechyporuk-Zloy; Michael Römer; Jürgen Reinhardt; Dietmar Weinhold; Peter Dieterich; Christian Stock; Steven C Hebert
Journal:  J Cell Physiol       Date:  2006-01       Impact factor: 6.384

3.  Single plasma membrane K+ channel detection by using dual-color quantum dot labeling.

Authors:  Volodymyr Nechyporuk-Zloy; Christian Stock; Hermann Schillers; Hans Oberleithner; Albrecht Schwab
Journal:  Am J Physiol Cell Physiol       Date:  2006-03-22       Impact factor: 4.249

4.  DNA methyltransferase inhibition reverses epigenetically embedded phenotypes in lung cancer preferentially affecting polycomb target genes.

Authors:  Antje Hascher; Ann-Kristin Haase; Katja Hebestreit; Christian Rohde; Hans-Ulrich Klein; Maria Rius; Dominik Jungen; Anika Witten; Monika Stoll; Isabell Schulze; Seishi Ogawa; Rainer Wiewrodt; Lara Tickenbrock; Wolfgang E Berdel; Martin Dugas; Nils H Thoennissen; Carsten Müller-Tidow
Journal:  Clin Cancer Res       Date:  2013-12-13       Impact factor: 12.531

Review 5.  Mechanosensitive ion channels push cancer progression.

Authors:  Zoltán Pethő; Karolina Najder; Etmar Bulk; Albrecht Schwab
Journal:  Cell Calcium       Date:  2019-04-01       Impact factor: 6.817

6.  Intermediate conductance Ca2+ activated K+ channels are expressed and functional in breast adenocarcinomas: correlation with tumour grade and metastasis status.

Authors:  Nathalie Haren; Hafida Khorsi; Malika Faouzi; Ahmed Ahidouch; Henri Sevestre; Halima Ouadid-Ahidouch
Journal:  Histol Histopathol       Date:  2010-10       Impact factor: 2.303

7.  A proinvasive role for the Ca(2+) -activated K(+) channel KCa3.1 in malignant glioma.

Authors:  Kathryn L Turner; Avinash Honasoge; Stephanie M Robert; Michael M McFerrin; Harald Sontheimer
Journal:  Glia       Date:  2014-03-02       Impact factor: 7.452

8.  Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures.

Authors:  Chia-Hsueh Lee; Roderick MacKinnon
Journal:  Science       Date:  2018-05-04       Impact factor: 47.728

Review 9.  Cancer-Associated Intermediate Conductance Ca2+-Activated K⁺ Channel KCa3.1.

Authors:  Corinna J Mohr; Friederike A Steudel; Dominic Gross; Peter Ruth; Wing-Yee Lo; Reiner Hoppe; Werner Schroth; Hiltrud Brauch; Stephan M Huber; Robert Lukowski
Journal:  Cancers (Basel)       Date:  2019-01-17       Impact factor: 6.639

10.  Co-staining of KCa 3.1 Channels in NSCLC Cells with a Small-Molecule Fluorescent Probe and Antibody-Based Indirect Immunofluorescence.

Authors:  Kathrin Brömmel; Sarah Maskri; Etmar Bulk; Zoltan Pethő; Marius Rieke; Thomas Budde; Oliver Koch; Albrecht Schwab; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2020-10-21       Impact factor: 3.466

View more
  3 in total

1.  Co-staining of KCa 3.1 Channels in NSCLC Cells with a Small-Molecule Fluorescent Probe and Antibody-Based Indirect Immunofluorescence.

Authors:  Kathrin Brömmel; Sarah Maskri; Etmar Bulk; Zoltan Pethő; Marius Rieke; Thomas Budde; Oliver Koch; Albrecht Schwab; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2020-10-21       Impact factor: 3.466

Review 2.  Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy.

Authors:  Verena Hofschröer; Karolina Najder; Micol Rugi; Rayhana Bouazzi; Marco Cozzolino; Annarosa Arcangeli; Gyorgy Panyi; Albrecht Schwab
Journal:  Front Pharmacol       Date:  2021-01-19       Impact factor: 5.810

3.  KCa channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549).

Authors:  Felix Glaser; Petra Hundehege; Etmar Bulk; Luca Matteo Todesca; Sandra Schimmelpfennig; Elke Nass; Thomas Budde; Sven G Meuth; Albrecht Schwab
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.